Reliability and validity of the Korean version of the coronary revascularization outcome questionnaire

Table 5 Concurrent Validity of the CROQ-PTCA (K)

CROQ scale	SF-12		SAQ
	PCS (N = 209)	MCS (N = 209)	Physical Limitation Scale (N = 208)	Angina Stability Scale (N = 209)	Angina Frequency Scale (N = 209)	Treatment Satisfaction Scale (N = 209)	Quality of Life Scale (N = 209)
CROQ-PTCA Pre
Symptoms	0.13	-0.21**	0.54**	-0.17*	0.72**	0.44**	0.47**
Physical functioning	0.62**	0.23**	0.86**	0.38**	0.61**	0.18*	0.40**
Cognitive functioning	0.50**	0.34**	0.52**	0.22**	0.47**	0.09	0.28**
Psychosocial functioning	0.57**	0.31**	0.70**	0.28**	0.56**	0.23**	0.45**
	PCS (N = 169)	MCS (N = 169)	The Physical Limitation Scale (N = 160)	The Angina Stability Scale (N = 169)	The Angina Frequency Scale (N = 169)	The Treatment Satisfaction Scale (N = 169)	The Quality of Life scale (N = 169)
CROQ-PTCA Post
Symptoms	0.27**	0.08	0.57**	0.02	0.79**	0.17*	0.39**
Physical functioning	0.43**	0.22**	0.87**	0.28**	0.55**	0.16*	0.27**
Cognitive functioning	0.37**	0.43**	0.10	0.02	<0.01	0.14	0.02
Psychosocial functioning	0.49**	0.52**	0.33**	0.05	0.18*	0.19*	0.45**
Satisfaction	0.36**	0.32**	0.15	0.01	0.07	0.591*	0.19*
Adverse effects	0.07	-0.06	0.14	-0.14	0.06	0.15	0.22**

*p < 0.05 **p < 0.01
CROQ Coronary Revascularization Outcome Questionnaire, PTCA percutaneous transluminal coronary angioplasty, SAQ Seattle Angina Questionnaire, PCS physical component summary, MCS mental component summary

ISSN: 1477-7525